Viewing Study NCT00423150


Ignite Creation Date: 2025-12-24 @ 5:05 PM
Ignite Modification Date: 2026-02-01 @ 6:29 AM
Study NCT ID: NCT00423150
Status: TERMINATED
Last Update Posted: 2017-06-08
First Post: 2006-11-30
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Phase 2 Study of Temozolomide in Pre-Selected Advanced Aerodigestive Tract Cancers (Study P04273AM2)(TERMINATED)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Colorectal Neoplasm View
None Head and Neck Neoplasm View
None Carcinoma, Non-Small-Cell Lung View
None Esophageal Neoplasm View
Keywords: